BioCentury
ARTICLE | Clinical News

Cobiprostone: Phase II data

July 6, 2009 7:00 AM UTC

Top-line data from a double-blind, U.S. Phase II trial in 124 osteoarthritis and/or rheumatoid arthritis patients taking 500 mg naproxen twice daily showed that oral cobiprostone did not significantly...